Eli Lilly pauses vaccine trial as spike in coronavirus cases raises alarms

02:17

Drug maker Eli Lilly says it’s pausing enrollment on its experimental COVID antibody treatments, now at the critical Phase 3 stage of the process. It’s just the latest obstacle in the race to develop vaccines and treatments for the coronavirus. NBC national correspondent Miguel Almaguer reports for TODAY.